Notice of AGM and Annual Report & Accounts

ImmuPharma PLC (LSE AIM: IMM), the specialist drug discovery and development company, confirms that the Notice of Annual General Meeting (“AGM”) has today been posted to shareholders. The Annual Report and Accounts for the year ended 31 December 2024 has also been posted to shareholders today.

These documents will be available shortly, in electronic form, for download on the Company’s website www.immupharma.co.uk.

ImmuPharma’s AGM will be held on Thursday 12th June 2025 @ 11:00am (BST) at: The Malmaison Hotel, 18-21 Charterhouse Square, Barbican, London EC1M 6AH.